Log In
Print
BCIQ
Print
Print this Print this
 

Truvada, emtricitabine/tenofovir

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionFixed-dose combination of the nucleoside analog reverse transcriptase inhibitors (NRTI) emtricitabine and tenofovir
Molecular Target HIV reverse transcriptase
Mechanism of ActionHIV reverse transcriptase inhibitor
Latest Stage of DevelopmentMarketed
IndicationHIV / AIDS
Partner

Bristol-Myers Squibb Co.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today